Bicocca Open Archive

Logo unimib boa
POGLIANI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.264
AS - Asia 5.954
EU - Europa 5.242
SA - Sud America 982
Continente sconosciuto - Info sul continente non disponibili 339
AF - Africa 159
OC - Oceania 11
Totale 25.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.701
SG - Singapore 2.137
CN - Cina 1.402
IT - Italia 957
HK - Hong Kong 945
DE - Germania 808
RU - Federazione Russa 748
BR - Brasile 730
SE - Svezia 638
IE - Irlanda 614
VN - Vietnam 588
UA - Ucraina 559
CA - Canada 456
GB - Regno Unito 265
FR - Francia 202
IN - India 197
FI - Finlandia 140
BD - Bangladesh 116
KR - Corea 116
AR - Argentina 81
IQ - Iraq 63
JP - Giappone 60
NL - Olanda 58
TR - Turchia 58
ZA - Sudafrica 54
EC - Ecuador 51
MX - Messico 44
PK - Pakistan 43
AT - Austria 42
ES - Italia 42
PL - Polonia 35
DK - Danimarca 34
ID - Indonesia 34
CO - Colombia 32
SA - Arabia Saudita 31
BE - Belgio 29
VE - Venezuela 26
PH - Filippine 25
MA - Marocco 19
UZ - Uzbekistan 19
CL - Cile 18
EG - Egitto 18
PY - Paraguay 17
MY - Malesia 16
ET - Etiopia 14
EU - Europa 14
KE - Kenya 14
TN - Tunisia 14
JM - Giamaica 13
UY - Uruguay 13
LT - Lituania 12
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 10
BG - Bulgaria 9
NP - Nepal 9
AU - Australia 8
CR - Costa Rica 8
DZ - Algeria 8
OM - Oman 8
PE - Perù 8
RO - Romania 8
TH - Thailandia 8
AZ - Azerbaigian 7
PS - Palestinian Territory 7
CZ - Repubblica Ceca 6
JO - Giordania 6
KZ - Kazakistan 6
NI - Nicaragua 6
GT - Guatemala 5
IL - Israele 5
LB - Libano 5
AL - Albania 4
BH - Bahrain 4
HR - Croazia 4
HU - Ungheria 4
IR - Iran 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
TW - Taiwan 4
BO - Bolivia 3
BY - Bielorussia 3
HN - Honduras 3
KH - Cambogia 3
LK - Sri Lanka 3
MK - Macedonia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BW - Botswana 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GP - Guadalupe 2
KG - Kirghizistan 2
KW - Kuwait 2
NO - Norvegia 2
Totale 25.594
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.839
Ashburn 1.329
Singapore 1.128
Woodbridge 1.040
Hong Kong 927
Houston 753
San Jose 724
Fairfield 647
Dublin 600
Jacksonville 594
Chandler 458
Frankfurt am Main 400
Wilmington 375
Dearborn 324
New York 311
Milan 290
Seattle 261
Toronto 242
Princeton 227
Beijing 215
Cambridge 207
Chicago 190
Los Angeles 187
Santa Clara 181
Ho Chi Minh City 178
Council Bluffs 159
Hanoi 144
Hefei 142
The Dalles 135
Nanjing 129
Shanghai 126
Seoul 108
Dallas 104
Lawrence 103
Lachine 102
Altamura 100
Lauterbourg 98
Buffalo 83
Moscow 77
São Paulo 70
Rome 62
Göttingen 52
Boardman 47
Guangzhou 44
Nanchang 42
Changsha 40
Tokyo 39
San Diego 38
Andover 37
Columbus 37
London 33
Vienna 33
Shenyang 32
Atlanta 31
Orem 31
Ottawa 30
Brooklyn 29
Brussels 29
Montreal 29
Hebei 28
Munich 27
Warsaw 27
Rio de Janeiro 26
Helsinki 25
Haiphong 24
Johannesburg 24
Baghdad 22
Huizen 22
Denver 20
Tampa 20
Salt Lake City 19
Da Nang 18
Fremont 18
Fürstenwalde 18
Guayaquil 18
Jiaxing 18
Jinan 18
Phoenix 18
Tianjin 18
Chennai 17
Figino 17
Hangzhou 17
Lahore 17
Lissone 17
Manchester 17
Pune 17
Tashkent 17
Bologna 16
Dhaka 16
Norwalk 16
Redmond 16
Zhengzhou 16
Jeddah 15
New Delhi 15
Nürnberg 15
University Park 15
Boston 14
Mumbai 14
Brasília 13
Kunming 13
Totale 16.780
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 577
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 498
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia 466
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 457
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 450
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 423
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 420
A boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation 393
Imatinib long term effects study: three years of follow-up and assessment 385
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 385
Thrombosis of the splenoportal axis after splenectomy 358
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 358
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 322
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT 322
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 318
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 308
Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report 303
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection 300
Severe, reversible nelarabine-induced neuropathy and myelopathy 299
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 293
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 292
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 287
A prospective study on cardiovascular events after acute pulmonary embolism 279
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) 278
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 276
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease 275
Combined prophylactic low-molecular weight heparin and low dose aspirin reduces the occurrences of adverse pregnancy outcome in multiparous women with preeclampsia and intrauterine fetal growth restriction in antecedent pregnancy 274
Recurrent preeclapsia: The role of acquired and heritable thrombophilia 274
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies 273
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy 265
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma 265
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 261
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination 259
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 257
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 256
Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy 255
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 252
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 248
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 245
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: A case report 244
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study 243
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 240
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 238
Autoimmune hepatitis presenting as imatinib toxicity: description of a case and of therapeutic alternatives 236
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 236
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance 235
Atypical presentation of Upshaw-Schulman syndrome in a pregnant patient homozygous for V Leiden mutation 234
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 228
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 226
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone 225
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients 224
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 222
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM) 221
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: A randomized study 221
Platelet activation during plasma-reduced multicomponent PLT collection: A comparison between COBE Trima and Spectra LRS turbo cell separators 215
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 212
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds 212
Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease 210
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial 208
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) 208
Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 207
Crizotinib in anaplastic large-cell lymphoma 206
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies 204
Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000 - 2002 202
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00 199
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11) 197
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia 195
SIGNIFICANT REDUCTION IN FASTING BLOOD GLUCOSE IN NONDIABETIC PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB MESYLATE 195
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 193
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature 188
A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript 187
Development of c-Kit-expressing Small-Cell lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment 184
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: A prospective multicentre study 183
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 183
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenström's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system 182
Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program 178
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage 178
HOMOZYGOSITY FOR JAK2V617F IDENTIFIES MPD PATIENTS WITH A MORE SYMPTOMATIC DISEASE A RETROSPECTIVE STUDY ON 989 PATIENTS FROM THE GIMEMA-MPD WORKING PARTY 178
Low Efficiency of a Newly Introduced High-Density Microparticles Method for B Cell Depletion in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation 175
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials 173
From Vaquez to Dameshek through JAK…2 much for polycythemia vera to be feared? 171
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD 170
Advanced mast cell disease: an Italian Hematological Multicenter experience 170
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 170
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells 168
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes 167
Imatinib concentrations in human milk 166
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 166
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 163
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 161
Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions 160
Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate 158
Corticosteroids can reverse severe imatinib-induced hepatotoxicity 158
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma 158
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 157
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia 154
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 152
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [2] 151
Mast cell leukemia: A report of ten cases 149
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study 148
Totale 24.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022980 0 0 90 111 85 103 42 85 71 92 106 195
2022/20232.038 293 671 195 163 127 311 17 79 109 6 34 33
2023/20241.665 38 45 54 78 244 490 341 47 174 13 21 120
2024/20253.085 211 356 120 138 296 75 122 75 319 462 312 599
2025/20268.480 764 566 669 953 969 455 1.212 449 687 740 377 639
2026/2027933 226 356 351 0 0 0 0 0 0 0 0 0
Totale 25.951